- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04109417
Effect of Platelet-Rich Plasma Biomembrane on Enhancing Bone Regeneration Following Endodontic Surgery
September 27, 2019 updated by: salma genena, Alexandria University
Effect of Platelet-Rich Plasma Biomembrane on Enhancing Bone Regeneration Following Endodontic Surgery:A Prospective Randomized Clinical Trial
This study was conducted to evaluate clinical and radiographical outcome of using a standardized platelet-rich plasma (PRP) biomembrane following endodontic surgery and its correlation with the growth factors content in this concentrate.
Study Overview
Status
Completed
Conditions
Detailed Description
15 healthy patients of both genders, between 20 and 45 years of age, presenting with 22 anterior/premolar teeth in need of endodontic surgery were recruited.
Teeth presented with failed non-surgical root canal therapy and periapical radiolucency of ≥ 1cm in size.
Patients were randomly divided following surgery into two groups, with 11 teeth each.
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Alexandria, Egypt, 21512
- Faculty of Dentistry, Alexandria University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy patients.
- Selected tooth with previous root canal therapy failure and in need of endodontic surgery.
- Existence of a periapical radiographic lesion surrounding the root canal treated tooth, of size ≥ 1 cm.
- Healthy periodontal condition (probing depth, mobility & epithelial attachment level are all within normal range).
Exclusion Criteria:
- Leaking coronal restoration.
- Periodontal ligament breakdown and presence of apicomarginal defects.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: osteotomy filled with PRP-gel and covered with PRP-biomembrane
the defect was filled with the previously activated autologous Platelet-rich plasma (PRP) gel and its supernatant.
The site was then externally covered with the prepared bio-membrane composed of activated PRP which acted as an adjunct to the mucoperiosteal flap to stimulate tissue regeneration
|
|
Sham Comparator: osteotomy site left empty
osteotomy site following the surgical intervention was left empty
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
degree of periapical inflammation using periapical index (PAI)
Time Frame: baseline
|
The PAI is a 5-point scale radiographic interpretation designed to determine the absence, presence, or transformation of a disease state.
Each of the roots was categorized as: (1) Normal periapical structure; (2) small changes in bone structure; (3) changes in bone structure with some mineral loss; (4) periodontitis with well-defined radiolucent area; and (5) severe periodontitis with exacerbating features.
Each category used in the PAI represents a step on an ordinal scale of registration of periapical infection.
|
baseline
|
degree of periapical inflammation using periapical index (PAI)
Time Frame: 3 months
|
The PAI is a 5-point scale radiographic interpretation designed to determine the absence, presence, or transformation of a disease state.
Each of the roots was categorized as: (1) Normal periapical structure; (2) small changes in bone structure; (3) changes in bone structure with some mineral loss; (4) periodontitis with well-defined radiolucent area; and (5) severe periodontitis with exacerbating features.
Each category used in the PAI represents a step on an ordinal scale of registration of periapical infection.
|
3 months
|
degree of periapical inflammation using periapical index (PAI)
Time Frame: 6 months
|
The PAI is a 5-point scale radiographic interpretation designed to determine the absence, presence, or transformation of a disease state.
Each of the roots was categorized as: (1) Normal periapical structure; (2) small changes in bone structure; (3) changes in bone structure with some mineral loss; (4) periodontitis with well-defined radiolucent area; and (5) severe periodontitis with exacerbating features.
Each category used in the PAI represents a step on an ordinal scale of registration of periapical infection.
|
6 months
|
degree of periapical inflammation using periapical index (PAI)
Time Frame: 9 months
|
The PAI is a 5-point scale radiographic interpretation designed to determine the absence, presence, or transformation of a disease state.
Each of the roots was categorized as: (1) Normal periapical structure; (2) small changes in bone structure; (3) changes in bone structure with some mineral loss; (4) periodontitis with well-defined radiolucent area; and (5) severe periodontitis with exacerbating features.
Each category used in the PAI represents a step on an ordinal scale of registration of periapical infection.
|
9 months
|
degree of periapical inflammation using periapical index (PAI)
Time Frame: 12 months
|
The PAI is a 5-point scale radiographic interpretation designed to determine the absence, presence, or transformation of a disease state.
Each of the roots was categorized as: (1) Normal periapical structure; (2) small changes in bone structure; (3) changes in bone structure with some mineral loss; (4) periodontitis with well-defined radiolucent area; and (5) severe periodontitis with exacerbating features.
Each category used in the PAI represents a step on an ordinal scale of registration of periapical infection.
|
12 months
|
degree of periapical inflammation using periapical index (PAI)
Time Frame: 18 months
|
The PAI is a 5-point scale radiographic interpretation designed to determine the absence, presence, or transformation of a disease state.
Each of the roots was categorized as: (1) Normal periapical structure; (2) small changes in bone structure; (3) changes in bone structure with some mineral loss; (4) periodontitis with well-defined radiolucent area; and (5) severe periodontitis with exacerbating features.
Each category used in the PAI represents a step on an ordinal scale of registration of periapical infection.
|
18 months
|
degree of periapical inflammation using CBCT periapical index (CBCTPAI)
Time Frame: baseline
|
CBCTPAI is a 6-point (0 -5) scoring system .The scores were calculated by analysis of the lesion in 3 dimensions, with CT slices being obtained in mesiodistal, buccopalatal, and diagonal directions.
The score was determined by the largest extension of the lesion.
The measurement of lesion depth in a CBCT image added the variables expansion of cortical bone (E) and destruction of cortical bone (D) usually detected starting from score 2.
|
baseline
|
degree of periapical inflammation using CBCT periapical index (CBCTPAI)
Time Frame: 18 months
|
CBCTPAI is a 6-point (0 -5) scoring system .The scores were calculated by analysis of the lesion in 3 dimensions, with CT slices being obtained in mesiodistal, buccopalatal, and diagonal directions.
The score was determined by the largest extension of the lesion.
The measurement of lesion depth in a CBCT image added the variables expansion of cortical bone (E) and destruction of cortical bone (D) usually detected starting from score 2.
|
18 months
|
changes in bone mineral density of lesions in CBCT images
Time Frame: baseline
|
region of interest measurements were made by the same operator in the sagittal view to provide consistency throughout the study protocol (baseline and at a 12 to 18 months post-operative interval).
ROI was selected through drawing a polyline pattern that enabled us to include all the confines of the lesion (On Demand 3D® viewing software was used to obtain a mean grey level using the region of interest (ROI) polyline tool in sagittal plane images.
The images of each CBCT scan were captured using the print screen button and exported into a Microsoft Word document as a record.
|
baseline
|
changes in bone mineral density of lesions in CBCT images
Time Frame: 18 months
|
region of interest measurements were made by the same operator in the sagittal view to provide consistency throughout the study protocol (baseline and at a 12 to 18 months post-operative interval).
ROI was selected through drawing a polyline pattern that enabled us to include all the confines of the lesion (On Demand 3D® viewing software was used to obtain a mean grey level using the region of interest (ROI) polyline tool in sagittal plane images.
The images of each CBCT scan were captured using the print screen button and exported into a Microsoft Word document as a record.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Platelet count in whole blood sample and in platelet rich plasma concentrate
Time Frame: baseline
|
Platelet count in whole blood sample and in platelet rich plasma concentrate is assessed to detect fold increase in platelet count
|
baseline
|
concentration of Platelet-derived growth factor (PDGF) in the prepared PRP
Time Frame: baseline
|
concentration of Platelet-derived growth factor (PDGF) in the prepared PRP was quantified using ELISA methods (R&D Center, Tokyo, Japan).
The analyses were then performed as instructed by manufacturer
|
baseline
|
concentration of vascular endothelial growth factors (VEGF) in the prepared PRP
Time Frame: baseline
|
Concentrations of VEGF growth factors in PRP was quantified using ELISA methods (R&D Center, Tokyo, Japan).
The analyses were then performed as instructed by manufacturer
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: salma genena, PhD, Alexandria University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 24, 2014
Primary Completion (Actual)
September 12, 2017
Study Completion (Actual)
October 12, 2017
Study Registration Dates
First Submitted
September 25, 2019
First Submitted That Met QC Criteria
September 27, 2019
First Posted (Actual)
September 30, 2019
Study Record Updates
Last Update Posted (Actual)
September 30, 2019
Last Update Submitted That Met QC Criteria
September 27, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00010556
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Endodontic Disease
-
Damascus UniversityCompletedEndodontic Disease | Endodontic Re-treatment FailureSyrian Arab Republic
-
Cairo UniversityUnknownEndodontic Disease | Endodontic Re-treatment Failure
-
Nuh Naci Yazgan UniversityMersin UniversityCompletedEndodontic Disease | Endodontic InflammationTurkey
-
Lumendo AGAvaniaNot yet recruitingEndodontic TreatmentTurkey
-
University of North Carolina, Chapel HillWithdrawnLocal Anesthesia | Endodontic Disease | Endodontic Inflammation | Dental Anesthesia
-
Istanbul UniversityAbant Izzet Baysal University; Istanbul Kent UniversityCompletedApexification | Regenerative Endodontic | FractalsTurkey
-
Postgraduate Institute of Dental Sciences RohtakUnknownPeriodontal and Endodontic LesionIndia
-
Postgraduate Institute of Dental Sciences RohtakUnknownPeriodontal and Endodontic Lesion
-
University Hospital, BrestRecruiting
-
Reem Mahmoud Abdelkader AwadCompletedEndodontic DiseaseEgypt
Clinical Trials on osteotomy filled with PRP-gel and covered with PRP-biomembrane
-
Yasmine Ahmed Abd El-Maguid El-HadidyUnknownAtrophic Acne ScarEgypt
-
Corporation for the Aid of Burned ChildrenZimmer BiometCompleted
-
Peking University Third HospitalRecruitingPlatelet Rich Plasma | Osteochondral Lesion of Talus | MicrofracturesChina
-
Jose R. Reyes Memorial Medical CenterCompletedStriae GravidarumPhilippines
-
Adrien SchwitzguebelRecruitingTendinopathy | Tennis Elbow | Tendinosis | PRP | Extracorporal Shockwave Therapy (ESWT) | Tendon Needling (Peppering) | Extensor Carpi Radialis Brevis (ECRB)Switzerland
-
Fundación Eduardo AnituaRecruiting
-
Fundación Eduardo AnituaRecruiting
-
Liaocheng People's HospitalRecruitingPressure Injuries - Stage 3 | Pressure Injuries - Stage 4China
-
Seoul National University HospitalCompletedRotator Cuff TearKorea, Republic of